A376900 logo

ROKIT Healthcare Inc. Stock Price

KOSDAQ:A376900 Community·₩2.2t Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A376900 Share Price Performance

₩0
-14750.00 (-100.00%)
₩0
-14750.00 (-100.00%)
Price ₩0

A376900 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with minimal risk.

1 Risk
1 Reward

ROKIT Healthcare Inc. Key Details

₩26.2b

Revenue

₩10.6b

Cost of Revenue

₩15.7b

Gross Profit

₩18.5b

Other Expenses

-₩2.8b

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
-180.78
59.70%
-10.84%
223.8%
View Full Analysis

About A376900

Founded
2012
Employees
72
CEO
Seok-hwan Yoo
WebsiteView website
rokithealthcare.com

ROKIT Healthcare Inc., a biotechnology company, provides hyper-personalized organ regenerative healthcare solutions in South Korea. The company offers skin regeneration therapy for the treatment of diabetic foot ulcers; cartilage regeneration delivers hyper-personalized therapeutic solutions for osteoarthritis patients; and kidney regeneration, a hyper-personalized treatment for chronic kidney disease (CKD). It also provides bioprinters; bioinks; Huma Media, a human adult stem cell culture media; HumaTein, a human cell-derived whole extracellular matrix; EpiTem, a reconstructed human epidermis model; and anti-aging supplements, as well as operates a tissue bank. The company was formerly known as ROKIT Inc. and changed its name to ROKIT Healthcare Inc. in 2018. The company was incorporated in 2012 and is based in Seoul, South Korea.

Recent A376900 News & Updates

Recent updates

No updates